Holland Richard, Lenaghan Elizabeth, Harvey Ian, Smith Richard, Shepstone Lee, Lipp Alistair, Christou Maria, Evans David, Hand Christopher
School of Medicine, Health Policy and Practice, University of East Anglia, Norwich NR4 7TJ.
BMJ. 2005 Feb 5;330(7486):293. doi: 10.1136/bmj.38338.674583.AE. Epub 2005 Jan 21.
To determine whether home based medication review by pharmacists affects hospital readmission rates among older people.
Randomised controlled trial.
Home based medication review after discharge from acute or community hospitals in Norfolk and Suffolk.
872 patients aged over 80 recruited during an emergency admission (any cause) if returning to own home or warden controlled accommodation and taking two or more drugs daily on discharge.
Two home visits by a pharmacist within two weeks and eight weeks of discharge to educate patients and carers about their drugs, remove out of date drugs, inform general practitioners of drug reactions or interactions, and inform the local pharmacist if a compliance aid is needed. Control arm received usual care.
Total emergency readmissions to hospital at six months. Secondary outcomes included death and quality of life measured with the EQ-5D.
By six months 178 readmissions had occurred in the control group and 234 in the intervention group (rate ratio = 1.30, 95% confidence interval 1.07 to 1.58; P = 0.009, Poisson model). 49 deaths occurred in the intervention group compared with 63 in the control group (hazard ratio = 0.75, 0.52 to 1.10; P = 0.14). EQ-5D scores decreased (worsened) by a mean of 0.14 in the control group and 0.13 in the intervention group (difference = 0.01, -0.05 to 0.06; P = 0.84, t test).
The intervention was associated with a significantly higher rate of hospital admissions and did not significantly improve quality of life or reduce deaths. Further research is needed to explain this counterintuitive finding and to identify more effective methods of medication review.
确定药剂师进行的居家药物评估是否会影响老年人的医院再入院率。
随机对照试验。
在诺福克和萨福克郡的急症或社区医院出院后进行居家药物评估。
872名80岁以上的患者,在因任何原因紧急入院后,如果返回自己家中或由监护人控制的住所,且出院时每天服用两种或更多药物,则纳入研究。
药剂师在出院后两周和八周内进行两次家访,向患者和护理人员讲解药物知识,清除过期药物,将药物不良反应或相互作用告知全科医生,如需辅助用药则通知当地药剂师。对照组接受常规护理。
六个月内急诊再入院的总数。次要观察指标包括死亡情况以及用EQ-5D量表测量的生活质量。
到六个月时,对照组发生178次再入院,干预组发生234次再入院(率比 = 1.30,95%置信区间1.07至1.58;P = 0.009,泊松模型)。干预组有49人死亡,对照组有63人死亡(风险比 = 0.75,0.52至1.10;P = 0.14)。对照组EQ-5D评分平均下降(恶化)0.14,干预组下降0.13(差异 = 0.01,-0.05至0.06;P = 0.84,t检验)。
该干预措施与显著更高的入院率相关,并未显著改善生活质量或降低死亡率。需要进一步研究来解释这一与直觉相悖的发现,并确定更有效的药物评估方法。